Movement Disorders (revue) - Exploration (Accueil)

Index « Mesh.i » - entrée « Injections, Subcutaneous »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Injections, Spinal < Injections, Subcutaneous < Inosine Pranobex  Facettes :

List of bibliographic references indexed by Injections, Subcutaneous

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]
Ident.Authors (with country if any)Title
001375 (2011) Javier Arpa [Espagne] ; Irene Sanz-Gallego [Espagne] ; Josmarlin Medina-Báez [Espagne] ; Luis Valmor Cruz Portela [Brésil] ; Laura Bannach Jardim [Brésil] ; Ignacio Torres-Aleman [Espagne] ; Jonas Alex Morales Saute [Brésil]Subcutaneous insulin‐like growth factor‐1 treatment in spinocerebellar ataxias: An open label clinical trial
002046 (2009) Kiyoka Kinugawa [France] ; Emmanuel Itti [France] ; Jean-Francois Lepeintre [France] ; Ivan Mari [France] ; Virginie Czernecki [France] ; Francoise Heran [France] ; Stephane Clemenceau [France] ; Marie Vidailhet [France] ; Emmanuel Roze [France]Subacute dopa‐responsive parkinsonism after successful surgical treatment of aqueductal stenosis
003313 (2006) Pedro J. Garcia Ruiz [Espagne]Nocturnal subcutaneous apomorphine infusion for severe insomnia in Parkinson's disease
003441 (2006) Angela Deutschl Nder [Allemagne] ; Friedrich Asmus [Allemagne] ; Elena Marelli [Allemagne] ; Thomas Klopstock [Allemagne] ; Thomas Gasser [Allemagne] ; Kai Bötzel [Allemagne]Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication
003548 (2006) Fredricka C. Martin [États-Unis] ; Adrian Handforth [États-Unis]Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor
003837 (2005) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, Finlande] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni]Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates
003968 (2005) Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Hughes [Australie] ; Andrew Evans [Royaume-Uni] ; Alice J. Manson [Royaume-Uni] ; Marion Hoffman [Australie] ; Lesley Swinn [Royaume-Uni] ; Hilary Watt [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges
003B76 (2004) Andrew H. Evans [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; Dominic Paviour [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Silke Appel [Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome
003C68 (2004) Svenja Happe [Allemagne] ; Tobias Tings [Allemagne] ; Kathrin Helmschmied [Allemagne] ; Karin Neubert [Allemagne] ; Wolfgang Wuttke [Allemagne] ; Walter Paulus [Allemagne] ; Claudia Trenkwalder [Allemagne]Levodopa treatment does not affect low‐dose apomorphine test in patients with Parkinson's disease
003D31 (2004) Lisa Jerome [États-Unis] ; Rick Doblin [États-Unis] ; Michael Mithoefer [États-Unis]Ecstasy use–Parkinson's disease link tenuous
003D65 (2004) Montse Alegret [Espagne] ; Francesc Valldeoriola [Espagne] ; Majosé Martí [Espagne] ; Manuela Pilleri [Espagne] ; Carme Junqué [Espagne] ; Jordi Rumià [Espagne] ; Eduardo Tolosa [Espagne]Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease
004226 (2002) Petr Kanovsk [République tchèque] ; Dagmar Kubová ; Martin Bares ; Hana Hortová ; Hana Streitová ; Ivan Rektor ; Vladimír ZnojilLevodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up.
004481 (2002) Guillermo Paradiso [Canada] ; Farooq Khan [Canada] ; Robert Chen [Canada]Effects of apomorphine on flexor reflex and periodic limb movement
004661 (2001) Han-Cheng Wang [Taïwan] ; Yoloung Hsieh [Taïwan]Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy
004956 (2000) Frank Birklein [Allemagne] ; Frank Erbguth [Allemagne]Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A—A preliminary observation
004958 (2000) Stewart A. Factor [États-Unis] ; Diane L. Brown [États-Unis] ; Eric S. Molho [États-Unis]Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease
004B41 (2000) Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Apomorphine: An underutilized therapy for Parkinson's disease
004E85 (1998) van Laar ; Bob Van Hilten ; Cees Neef ; A. Wijnand F. Rutgers ; Stan Pavel ; J. Anthony BruijnThe role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: A histologic study
005069 (1998) John D. O'Sullivan [Australie] ; Andrew J. Hughes [Australie]Apomorphine‐induced penile erections in Parkinson's disease
005079 (1998) Pierre J. Blanchet [États-Unis] ; Spyridon Konitsiotis [États-Unis] ; Thomas N. Chase [États-Unis]Amantadine reduces levodopa‐induced dyskinesias in parkinsonian monkeys
005564 (1996) Burton L. Scott [États-Unis] ; Randolph W. Evans [États-Unis] ; Joseph Jankovic [États-Unis]Treatment of palatal myoclonus with sumatriptan

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Injections, Subcutaneous" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Injections, Subcutaneous" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Injections, Subcutaneous
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024